Three Year Results from the United States FDA Prospective Multicenter Clinical Study of the EVO/EVO+ Implantable Collamer Lens
This 3-year study confirmed the central port design of the EVO ICL functions effectively to allow physiologic flow of aqueous humor, thus eliminating the requirement for preoperative PI and reducing the incidence of ASC and pupillary block. EVO ICL lenses demonstrated accuracy and stability of refractive correction and achievement of high levels of UDVA.
Authors
- Scott W. Perkins
- Zachary Zavodni
- Jason Stahl
- Jeffrey D. Whitman (ORCID: https://orcid.org/0000-0002-3502-5799)
- Alan D. Faulkner (ORCID: https://orcid.org/0000-0002-4098-7466)
- Lance J. Kugler (ORCID: https://orcid.org/0000-0003-2007-582X)
- Jason Philip Brinton (ORCID: https://orcid.org/0000-0001-8385-2898)
- Mark Packer (ORCID: https://orcid.org/0000-0003-2681-6641)
- Francis W. Price (ORCID: https://orcid.org/0000-0001-9298-0250)
- Jonathan Solomon
- Vance Thompson (ORCID: https://orcid.org/0000-0003-2198-841X)
- Michael Aronsky
- Gregory Parkhurst (ORCID: https://orcid.org/0000-0002-9946-8724)
- William F. Wiley
- Majid Moshirfar
- Joanne Egamino
Institutions
- University of Nebraska at Omaha (US)
- Vance Thompson Vision (US)
- Key-Whitman Eye Center (US)
- Durrie Vision (US)
- Arkema (United States) (US)
- Price Vision Group (US)
- Tekwani Vision Center (US)
- Forest Research (GB)
- Eye Care Associates (US)
- Midwest Eye Center (US)
- Eye Institute of Utah (US)
- Hoopes Vision (US)
- Cornea and Laser Eye Institute - Hersh Vision Group (US)
- Cleveland Eye Clinic (US)
- McKinsey & Company (United States) (US)
Publication Details
- Journal
- Clinical ophthalmology
- Published
- 2025-09-01
- DOI
- https://doi.org/10.2147/opth.s537739
- Citations
- 1
- Primary Topic
- Corneal surgery and disorders
- Type
- article
- Field-Weighted Citation Impact
- 1.36